Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Baron and Budd Seeks to Help Women Harmed by YAZ, Yasmin, Beyaz and Ocella0

Baron and Budd, a national law firm dedicated to Protecting What’s Right, is stepping up to help women who have suffered serious health issues from the oral contraceptives YAZ, Yasmin, Beyaz and Ocella. Bayer,...

RBCC Target’s Brain Injury Treatment Awareness Campaign Reaches Milestone

Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp., today announced the collaboration of its latest target, Amarantus BioSciences, Inc., with Brewer Sports International to increase awareness about new medical therapies in development to effectively treat traumatic...

Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference

Biogen Idec Inc. announced today that its presentation at the Deutsche Bank 37th Annual Healthcare Conference will be webcast live on Tuesday, May 8, 2012 at 10:00 a.m. ET. To access the live webcast, please visit...

Anacor Pharmaceuticals to Present at the Deutsche Bank Annual Health Care Conference

Anacor Pharmaceuticals announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Deutsche Bank Annual Health Care Conference on Monday May 7, 2012 at 4:10 p.m. ET in Boston, Massachusetts. ...

ClinStar to Present at Outsourcing in Clinical Trials Europe

ClinStar, LLC, an established clinical research organization providing clinical development services in the emerging markets of Russia and Eastern Europe to the biopharmaceutical industry, announced today that President and CEO David Passov will present at Outsourcing in Clinical...

Novasep strengthens its management team with the appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites...

Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive committee, while Alain Lamproye joins Novasep...

Adocia reports positive phase II clinical results for the treatment of diabetic foot ulcer

Adocia, a biotechnology company specialized in the development of best-in-class medicines with already approved therapeutic proteins, announces today positive results from its Phase II clinical trial evaluating the safety and efficacy of BioChaperone(R) combined with PDGF-BB for the treatment...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »